Shruti Bhat, review artcile, Chemical weekly, 1997.
http://www.allbusiness.com/ / pharmaceutical-biotechnology.
Brahmankar D. M., Jaiswal S. B. Controlled Release Medication in Biopharmaceutics and Pharmacokinetics a Treatise. 1st edition, Vallabh Prakashan, Delhi, 1995; 335-371.
Lachman Leon, Lieberman H. A., Kanig J. L.The Theory and Practice of Industrial Pharmacy. 3 rd edition, Varghese Publishing House, Bombay, 1987; 430-456.
Chien Y. W. Novel drug Delivery Systems. Marcel Dekker, 1982; 171-177.
A J Moës.Gastric retention system for oral drug delivery. Drug Delivery Oral.2005. http://www.bbriefings.com/pdf/890/PT04_moes.pdf.
Jian-Hwa Guo, PhD ,Carbopol polymers for pharmaceutical drug delivery applications. Excipient Updates. Drug Delivery Technology. http://www.drugdeliverytech.com/cgi-bin/articles.cpi?idArticle=159.
Seham S. Abd E Hady, Nahed D. Mortada, Gehanne A. S. Awad, Noha M. Zaki, Ragia A. Taha. Development of in situ gelling and mucoadhesive mebeverine hydrochloride solution for rectal administration. Saudi Pharmaceutical Journal. 2003; 11(4):159-171.
Khalid U. Shah, PhD & Jose G. Rocca, PhD. Lectins as next generation mucoadhesive for specific targeting of the gastrointestinal tract. Gastrointestinal Targeting, Drug Delivery Technology. http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=245.
Kok Khiang Peh, Choy Fun Wong. Polymeric films as vehicle for buccal delivery: Swelling, mechanical and bioadhesive properties. Journal of Pharmacy and Pharmaceutical Sciences. 1999; 2(2):53-61.
Kashappa Goud, H. Desai, and T.M. Pramod Kumar.Preparation and evaluation of a novel buccal adhesive system.AAPS PharmSciTech. 2004; 5(3):article 35.
Joe McDonough and Wade Schlameus.Uncontrolled growth of controlled selease drug delivery technology and markets. Pharmaceutical Research and Microencapsulation Specialists at the Southwest Research Institute.
Costas Kaparissides, Sofia Alexandridou, Katerina Kotti and Sotira Chaitidou.Recent advances in novel drug delivery systems. Azojono Journal Of Nanotechnology.2006; 10:2240/1110.
Woodley, John .Bioadhesion: New Possibilities for Drug Administration. Leading Article.Clinical Pharmacokinetics. 2001; 40(2):77-84.
Juan Manuel Llabot, Ruben Hilario Manzo and Daniel Alberto Allemandi. Double-layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech 2002; 3 (3) article 22
K.P.R. Chowdary and Y. Srinivasa Rao .Design and in vitro and in vivo evaluation of mucoadhesive microcapsulesof glipizide for oral controlled release: a technical note. AAPS PharmSciTech 2003; 4 (3) Article 39.
M.S. El-Samaligy, N.N. Afifi, E.A. Mahmoud .Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation. International Journal of Pharmaceutics 2006; 308:140–148.
Libero Italo Giannola , Viviana De Caro , Giulia Giandalia ,Maria Gabriella Siragusa , Claudio Tripodo , Ada Maria Florena , Giuseppina Campisi . Release of naltrexone on buccal mucosa: Permeation studies, histological aspects and matrix system design. European Journal of Pharmaceutics and Biopharmaceutics. 2007.
Ana Figueiras , Rui A. Carvalho , Laura Ribeiro , Juan J. Torres-Labandeira Francisco J.B. Veiga .Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified b-cyclodextrin.ssuropean Journal of Pharmaceutics and Biopharmaceutics. 2007.
Axel Schneeweis, Christel C. Muller-Goymann. Controlled release of solid-reversed-micellar-solution (SRMS) suppositories containing metoclopramide-HCl. International Journal of Pharmaceutics. 2000; 196:193–196.
Ulrich Klotz, Matthias Schwab .Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Advanced Drug Delivery. 2005; 57:267-279.
ST Lim, B Forbes, GP Martin, and MB Brown. In vivo and in vitro characterization of novel micro particulates based on hyaluronan and chitosan hydroglutamate.AAPS PharmSciTech2001; 2 (4) article
Sambhaji Pisal, Vijay Shelke, Kakasaheb Mahadik,Shivajirao Kadam. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech 2004; 5 (4) Article 63.
E. Gavini , A.B. Hegge , G. Rassu a, V. Sanna , C. Testa ,G. Pirisino , J. Karlsen , P. Giunchedi.Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. International Journal of Pharmaceutics .2006; 307:9-15.
Sonal R. Patel , Hui Zhong , Ashutosh Sharma , Yogeshvar N. Kalia. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.European Journal of Pharmaceutics and Biopharmaceutics.2007; 66: 296–301.
Hongxia Lin , Matthias Gebhardt , Shengjie Bian , Kyoung Ae Kwon ,Chang-Koo Shim, Suk-Jae Chung, Dae-Duk Kim. Enhancing effect of surfactants on fexofenadine·HCl transport across the human nasal epithelial cell monolayer. International Journal of Pharmaceutics.2007; 330:23–31.
Jean-Louis Bourges, Sandrine E. Gautier, Florence Delie, Riad A. Bejjani, Jean-Claude Jeanny, Robert Gurny, David Ben Ezra, and Francine F. Behar-Cohen. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticses. Investigative Ophthalmology and Visual Science. 2003; 44:3562-3569.
For an expert opinion on formulation development of peptide/ protein molecules http://www.drshrutibhat.com
My other blog that might be of interest - http://www.qa-expert.com/
0 comments:
Post a Comment